Company Profile of Suzhou Pharmaserve Technology Co., Ltd.

Suzhou Pharmaserve Technology Co., Ltd., established in 2019, is a leading developer and global supplier of high-quality Active Pharmaceutical Ingredients (APIs). Headquartered in Suzhou Industrial Park, China, we specialize in delivering cost-effective and innovative solutions to pharmaceutical manufacturers worldwide. Our mission—Caring for Life, Better Health, Affordable API—guides our commitment to ensuring access to safe and affordable medicines for patients across the globe.

At Pharmaserve, we excel in the development, production, and marketing of APIs, with a strong focus on three core categories:

1. Peptides:  GLP-1 receptor agonists such as Semaglutide, Tirzepatide, and Liraglutide, which are pivotal in the treatment of Type 2 diabetes and obesity.
2. Cephalosporins: High-quality APIs compliant with global regulatory standards.
3. Advanced API Tech-Transfer Services: Enabling seamless production scaling and compliance for our partners.

We are recognized for adhering to rigorous international standards, including USP, EP, DMF, and CEP, ensuring the highest levels of safety, efficacy, and compliance.

With an extensive client base in 44 countries, including both regulated markets (USA, Europe, Japan) and emerging markets (Southeast Asia, Middle East, Latin America), we play a vital role in improving global healthcare accessibility. Our APIs empower generic pharmaceutical manufacturers to achieve faster time-to-market while maintaining cost efficiency.